nodes	percent_of_prediction	percent_of_DWPC	metapath
Loteprednol—NR3C1—hypertension	0.381	1	CbGaD
Loteprednol—NR3C1—Spironolactone—hypertension	0.107	1	CbGbCtD
Loteprednol—Potassium Canrenoate—Spironolactone—hypertension	0.0414	0.0892	CrCrCtD
Loteprednol—Hydrocortamate—Eplerenone—hypertension	0.035	0.0754	CrCrCtD
Loteprednol—Cortisone acetate—Eplerenone—hypertension	0.0339	0.073	CrCrCtD
Loteprednol—Hydrocortamate—Spironolactone—hypertension	0.0304	0.0656	CrCrCtD
Loteprednol—Fluoxymesterone—Eplerenone—hypertension	0.0302	0.0651	CrCrCtD
Loteprednol—Cortisone acetate—Spironolactone—hypertension	0.0295	0.0635	CrCrCtD
Loteprednol—Testosterone Propionate—Eplerenone—hypertension	0.0295	0.0634	CrCrCtD
Loteprednol—Fludrocortisone—Eplerenone—hypertension	0.0295	0.0634	CrCrCtD
Loteprednol—Methyltestosterone—Eplerenone—hypertension	0.0287	0.0618	CrCrCtD
Loteprednol—Testolactone—Spironolactone—hypertension	0.0286	0.0616	CrCrCtD
Loteprednol—Fluoxymesterone—Spironolactone—hypertension	0.0263	0.0567	CrCrCtD
Loteprednol—Testosterone Propionate—Spironolactone—hypertension	0.0256	0.0552	CrCrCtD
Loteprednol—Fludrocortisone—Spironolactone—hypertension	0.0256	0.0552	CrCrCtD
Loteprednol—Methyltestosterone—Spironolactone—hypertension	0.025	0.0538	CrCrCtD
Loteprednol—Hydrocortisone—Eplerenone—hypertension	0.024	0.0517	CrCrCtD
Loteprednol—Hydrocortisone—Spironolactone—hypertension	0.0209	0.045	CrCrCtD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXF1—hypertension	0.00157	0.0431	CbGpPWpGaD
Loteprednol—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—SRF—hypertension	0.00125	0.0343	CbGpPWpGaD
Loteprednol—NR3C1—urine—hypertension	0.00119	0.201	CbGeAlD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—HDAC5—hypertension	0.000808	0.0222	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—RCHY1—hypertension	0.000775	0.0213	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—SRF—hypertension	0.000715	0.0197	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—GATA6—hypertension	0.000712	0.0196	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—NR3C2—hypertension	0.000621	0.0171	CbGpPWpGaD
Loteprednol—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—hypertension	0.000602	0.0166	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—UCP2—hypertension	0.000579	0.0159	CbGpPWpGaD
Loteprednol—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—hypertension	0.000577	0.0159	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALAS1—hypertension	0.000561	0.0154	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—hypertension	0.000561	0.0154	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—hypertension	0.00053	0.0146	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—HDAC6—hypertension	0.000521	0.0143	CbGpPWpGaD
Loteprednol—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—hypertension	0.0005	0.0138	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—KCNJ11—hypertension	0.000493	0.0136	CbGpPWpGaD
Loteprednol—NR3C1—cardiac ventricle—hypertension	0.000465	0.0783	CbGeAlD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—hypertension	0.000457	0.0126	CbGpPWpGaD
Loteprednol—NR3C1—myocardium—hypertension	0.000437	0.0736	CbGeAlD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—hypertension	0.000429	0.0118	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—NFATC2—hypertension	0.000393	0.0108	CbGpPWpGaD
Loteprednol—Prednisone—HSD11B1—hypertension	0.000388	0.0675	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—SGK1—hypertension	0.000379	0.0104	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—ADRBK1—hypertension	0.000357	0.00983	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—GATA4—hypertension	0.000356	0.00979	CbGpPWpGaD
Loteprednol—Amcinonide—ANXA1—hypertension	0.000355	0.0618	CrCbGaD
Loteprednol—NR3C1—Nuclear Receptors—ESR2—hypertension	0.000354	0.00975	CbGpPWpGaD
Loteprednol—NR3C1—brainstem—hypertension	0.000353	0.0594	CbGeAlD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—LEP—hypertension	0.000348	0.00959	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—RETN—hypertension	0.000346	0.00951	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—DUSP1—hypertension	0.000344	0.00946	CbGpPWpGaD
Loteprednol—NR3C1—nephron tubule—hypertension	0.000321	0.054	CbGeAlD
Loteprednol—NR3C1—adrenal cortex—hypertension	0.000315	0.0531	CbGeAlD
Loteprednol—NR3C1—Nuclear Receptors—AR—hypertension	0.000313	0.00862	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—F7—hypertension	0.000312	0.0086	CbGpPWpGaD
Loteprednol—NR3C1—heart—hypertension	0.000305	0.0514	CbGeAlD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—PPARG—hypertension	0.000304	0.00836	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—NPPA—hypertension	0.000303	0.00834	CbGpPWpGaD
Loteprednol—NR3C1—smooth muscle tissue—hypertension	0.000303	0.051	CbGeAlD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—hypertension	0.000301	0.00829	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—KCNJ8—hypertension	0.000299	0.00822	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—KCNQ1—hypertension	0.000299	0.00822	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypertension	0.000297	0.00818	CbGpPWpGaD
Loteprednol—NR3C1—decidua—hypertension	0.000297	0.05	CbGeAlD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYOD1—hypertension	0.00029	0.00798	CbGpPWpGaD
Loteprednol—NR3C1—cardiovascular system—hypertension	0.000288	0.0485	CbGeAlD
Loteprednol—NR3C1—kidney—hypertension	0.000282	0.0474	CbGeAlD
Loteprednol—NR3C1—Nuclear Receptors—VDR—hypertension	0.000281	0.00774	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—ESR2—hypertension	0.00028	0.00771	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—ECE1—hypertension	0.000278	0.00765	CbGpPWpGaD
Loteprednol—NR3C1—cortex of kidney—hypertension	0.000274	0.0462	CbGeAlD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—SELE—hypertension	0.000267	0.00735	CbGpPWpGaD
Loteprednol—NR3C1—cardiac atrium—hypertension	0.000261	0.0439	CbGeAlD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—EGR1—hypertension	0.000254	0.00699	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—MIF—hypertension	0.000252	0.00694	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PTGIS—hypertension	0.000252	0.00694	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—SLC9A3—hypertension	0.000248	0.00681	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—AR—hypertension	0.000247	0.00681	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—HDAC1—hypertension	0.000247	0.00679	CbGpPWpGaD
Loteprednol—NR3C1—medulla oblongata—hypertension	0.000246	0.0414	CbGeAlD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—hypertension	0.000242	0.00667	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—AR—hypertension	0.00024	0.0066	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—PPARA—hypertension	0.000237	0.00653	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—IL13—hypertension	0.000236	0.00651	CbGpPWpGaD
Loteprednol—Fludrocortisone—NR3C2—hypertension	0.000234	0.0407	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TIMP1—hypertension	0.000229	0.00632	CbGpPWpGaD
Loteprednol—NR3C1—adrenal gland—hypertension	0.000228	0.0383	CbGeAlD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—VDR—hypertension	0.000222	0.00612	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—PPARGC1A—hypertension	0.000219	0.00604	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—AVP—hypertension	0.000216	0.00596	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TH—hypertension	0.000216	0.00594	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—GATA4—hypertension	0.000212	0.00583	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—TPH1—hypertension	0.00021	0.00579	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hypertension	0.000204	0.00561	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—EGR1—hypertension	0.000203	0.0056	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—hypertension	0.000198	0.00545	CbGpPWpGaD
Loteprednol—NR3C1—endocrine gland—hypertension	0.000197	0.0333	CbGeAlD
Loteprednol—NR3C1—Nuclear Receptors—PPARG—hypertension	0.000196	0.0054	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—GJA1—hypertension	0.000194	0.00533	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—AHR—hypertension	0.000189	0.00521	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—hypertension	0.000189	0.0052	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—PPARA—hypertension	0.000187	0.00516	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HADHA—hypertension	0.000183	0.00504	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—hypertension	0.00018	0.00497	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—EGR1—hypertension	0.000179	0.00493	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—AQP4—hypertension	0.000179	0.00493	CbGpPWpGaD
Loteprednol—NR3C1—central nervous system—hypertension	0.000178	0.03	CbGeAlD
Loteprednol—NR3C1—Circadian Clock—PPARA—hypertension	0.000176	0.00486	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—PRL—hypertension	0.000176	0.00486	CbGpPWpGaD
Loteprednol—Hydrocortisone—CYP11B1—hypertension	0.000176	0.0307	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC1—hypertension	0.000176	0.00483	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—HDAC1—hypertension	0.000174	0.00479	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—HIF1A—hypertension	0.000172	0.00472	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—hypertension	0.000171	0.00471	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hypertension	0.000171	0.0047	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—EDN1—hypertension	0.00017	0.00467	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HSPD1—hypertension	0.000168	0.00463	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IL10—hypertension	0.000168	0.00462	CbGpPWpGaD
Loteprednol—Hydrocortisone—CYP11B2—hypertension	0.000166	0.0288	CrCbGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—TNF—hypertension	0.000161	0.00444	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—TACR1—hypertension	0.000159	0.00439	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hypertension	0.000157	0.00432	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—PPARG—hypertension	0.000155	0.00427	CbGpPWpGaD
Loteprednol—Prednisolone—NR3C2—hypertension	0.000154	0.0267	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—hypertension	0.000153	0.00423	CbGpPWpGaD
Loteprednol—Testosterone Propionate—CYP17A1—hypertension	0.000153	0.0266	CrCbGaD
Loteprednol—Betamethasone—NR3C2—hypertension	0.000151	0.0262	CrCbGaD
Loteprednol—Hydrocortisone—ANXA1—hypertension	0.00015	0.0261	CrCbGaD
Loteprednol—Exemestane—CYP19A1—hypertension	0.00015	0.0261	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hypertension	0.000149	0.00411	CbGpPWpGaD
Loteprednol—Testolactone—CYP19A1—hypertension	0.000143	0.0249	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MMP1—hypertension	0.000143	0.00393	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—HIF1A—hypertension	0.000141	0.00389	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL13—hypertension	0.000141	0.00389	CbGpPWpGaD
Loteprednol—Dexamethasone—CYP4A11—hypertension	0.000141	0.0246	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—AGT—hypertension	0.000141	0.00388	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—ADIPOQ—hypertension	0.000135	0.00373	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—SERPINE1—hypertension	0.000131	0.00362	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hypertension	0.000131	0.00361	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—NOTCH1—hypertension	0.00013	0.00359	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—IL6—hypertension	0.00013	0.00358	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—TAC1—hypertension	0.00013	0.00358	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SLC2A4—hypertension	0.000128	0.00352	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—SLC6A4—hypertension	0.000128	0.00351	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—MMP1—hypertension	0.000126	0.00346	CbGpPWpGaD
Loteprednol—Testosterone Propionate—COMT—hypertension	0.000124	0.0217	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—SST—hypertension	0.000124	0.00341	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL1RN—hypertension	0.000123	0.0034	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—FOS—hypertension	0.000119	0.00327	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CCL2—hypertension	0.000116	0.00319	CbGpPWpGaD
Loteprednol—Prednicarbate—NR3C1—hypertension	0.000116	0.0201	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—ESR2—hypertension	0.000114	0.00315	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hypertension	0.000114	0.00315	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—TH—hypertension	0.000114	0.00313	CbGpPWpGaD
Loteprednol—Dexamethasone—ANXA1—hypertension	0.000112	0.0194	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—PPARGC1A—hypertension	0.00011	0.00304	CbGpPWpGaD
Loteprednol—Desonide—NR3C1—hypertension	0.00011	0.0191	CrCbGaD
Loteprednol—Diflorasone—NR3C1—hypertension	0.00011	0.0191	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NR3C2—hypertension	0.000107	0.00295	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—EGR1—hypertension	0.000107	0.00295	CbGpPWpGaD
Loteprednol—Desoximetasone—NR3C1—hypertension	0.000107	0.0186	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hypertension	0.000106	0.00291	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—FOS—hypertension	0.000105	0.00288	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—POMC—hypertension	0.000104	0.00288	CbGpPWpGaD
Loteprednol—Fludrocortisone—AR—hypertension	0.000104	0.0181	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HDAC1—hypertension	0.000104	0.00286	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—GJA1—hypertension	0.000102	0.00281	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CDKN2A—hypertension	0.000101	0.00279	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—AR—hypertension	0.000101	0.00278	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—MAPK8—hypertension	0.000101	0.00278	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—LPL—hypertension	0.0001	0.00276	CbGpPWpGaD
Loteprednol—Beclomethasone—CYP3A5—hypertension	9.99e-05	0.0174	CrCbGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—EP300—hypertension	9.83e-05	0.00271	CbGpPWpGaD
Loteprednol—Medrysone—NR3C1—hypertension	9.7e-05	0.0169	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—hypertension	9.64e-05	0.00265	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—SRC—hypertension	9.56e-05	0.00263	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—EP300—hypertension	9.54e-05	0.00263	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—hypertension	9.53e-05	0.00262	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—GNB3—hypertension	9.53e-05	0.00262	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—AVP—hypertension	9.4e-05	0.00259	CbGpPWpGaD
Loteprednol—Testosterone Propionate—AR—hypertension	9.27e-05	0.0161	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CXCL8—hypertension	9.17e-05	0.00253	CbGpPWpGaD
Loteprednol—Hydrocortamate—NR3C1—hypertension	9.05e-05	0.0157	CrCbGaD
Loteprednol—Cortisone acetate—NR3C1—hypertension	8.9e-05	0.0155	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NEDD4L—hypertension	8.89e-05	0.00245	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PPARA—hypertension	8.87e-05	0.00244	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL10—hypertension	8.84e-05	0.00243	CbGpPWpGaD
Loteprednol—Dexamethasone—NR3C2—hypertension	8.76e-05	0.0152	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—HIF1A—hypertension	8.62e-05	0.00237	CbGpPWpGaD
Loteprednol—Fluoxymesterone—AR—hypertension	8.59e-05	0.015	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—AGT—hypertension	8.59e-05	0.00236	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—RELA—hypertension	8.58e-05	0.00236	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—LEP—hypertension	8.41e-05	0.00232	CbGpPWpGaD
Loteprednol—Amcinonide—NR3C1—hypertension	8.41e-05	0.0146	CrCbGaD
Loteprednol—Budesonide—NR3C1—hypertension	8.41e-05	0.0146	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—YWHAZ—hypertension	8.31e-05	0.00229	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MMP9—hypertension	8.3e-05	0.00228	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—PTEN—hypertension	8.25e-05	0.00227	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—NGF—hypertension	8.22e-05	0.00226	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—hypertension	8.08e-05	0.00223	CbGpPWpGaD
Loteprednol—Mometasone—NR3C1—hypertension	8e-05	0.0139	CrCbGaD
Loteprednol—Rimexolone—NR3C1—hypertension	7.91e-05	0.0138	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—EP300—hypertension	7.87e-05	0.00217	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HTR2A—hypertension	7.82e-05	0.00215	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—GATA4—hypertension	7.73e-05	0.00213	CbGpPWpGaD
Loteprednol—Beclomethasone—NR3C1—hypertension	7.46e-05	0.013	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HIF1A—hypertension	7.45e-05	0.00205	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hypertension	7.36e-05	0.00203	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—PPARG—hypertension	7.33e-05	0.00202	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hypertension	7.29e-05	0.00201	CbGpPWpGaD
Loteprednol—Alclometasone—NR3C1—hypertension	7.25e-05	0.0126	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—INS—hypertension	7.19e-05	0.00198	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hypertension	7.11e-05	0.00196	CbGpPWpGaD
Loteprednol—Clobetasol propionate—NR3C1—hypertension	7.06e-05	0.0123	CrCbGaD
Loteprednol—Fludrocortisone—NR3C1—hypertension	7.06e-05	0.0123	CrCbGaD
Loteprednol—Flunisolide—NR3C1—hypertension	7.06e-05	0.0123	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hypertension	7e-05	0.00193	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—TGFB1—hypertension	7e-05	0.00193	CbGpPWpGaD
Loteprednol—Paramethasone—NR3C1—hypertension	6.97e-05	0.0121	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—IGF1—hypertension	6.95e-05	0.00191	CbGpPWpGaD
Loteprednol—Methyltestosterone—AR—hypertension	6.94e-05	0.0121	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—EP300—hypertension	6.93e-05	0.00191	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hypertension	6.89e-05	0.0019	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MYC—hypertension	6.86e-05	0.00189	CbGpPWpGaD
Loteprednol—Ciclesonide—NR3C1—hypertension	6.86e-05	0.0119	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TGFB1—hypertension	6.84e-05	0.00188	CbGpPWpGaD
Loteprednol—Fluorometholone—NR3C1—hypertension	6.8e-05	0.0118	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NPPA—hypertension	6.74e-05	0.00186	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—SERPINE1—hypertension	6.6e-05	0.00182	CbGpPWpGaD
Loteprednol—Methylprednisolone—NR3C1—hypertension	6.58e-05	0.0114	CrCbGaD
Loteprednol—Dexamethasone—CYP17A1—hypertension	6.41e-05	0.0112	CrCbGaD
Loteprednol—Clobetasol propionate—CYP1A1—hypertension	6.41e-05	0.0112	CrCbGaD
Loteprednol—Dexamethasone—CYP11A1—hypertension	6.3e-05	0.011	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hypertension	6.1e-05	0.00168	CbGpPWpGaD
Loteprednol—Fluoxymesterone—NR3C1—hypertension	5.83e-05	0.0101	CrCbGaD
Loteprednol—Methyltestosterone—CYP19A1—hypertension	5.81e-05	0.0101	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TP53—hypertension	5.63e-05	0.00155	CbGpPWpGaD
Loteprednol—Betamethasone—CYP19A1—hypertension	5.6e-05	0.00975	CrCbGaD
Loteprednol—Triamcinolone—NR3C1—hypertension	5.54e-05	0.00965	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—CTGF—hypertension	5.29e-05	0.00146	CbGpPWpGaD
Loteprednol—Dexamethasone—NOS2—hypertension	5.22e-05	0.00909	CrCbGaD
Loteprednol—NR3C1—Gene Expression—NR3C2—hypertension	5.17e-05	0.00142	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IL6—hypertension	5.15e-05	0.00142	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—CDKN1A—hypertension	5.04e-05	0.00139	CbGpPWpGaD
Loteprednol—Prednisone—NR3C1—hypertension	5.03e-05	0.00875	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—TP53—hypertension	4.96e-05	0.00137	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—ESR2—hypertension	4.84e-05	0.00133	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—CXCL8—hypertension	4.83e-05	0.00133	CbGpPWpGaD
Loteprednol—Hydrocortisone—CYP3A5—hypertension	4.75e-05	0.00826	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL1B—hypertension	4.64e-05	0.00128	CbGpPWpGaD
Loteprednol—Prednisolone—NR3C1—hypertension	4.64e-05	0.00807	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NOTCH2—hypertension	4.58e-05	0.00126	CbGpPWpGaD
Loteprednol—Betamethasone—NR3C1—hypertension	4.54e-05	0.0079	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—IL6—hypertension	4.54e-05	0.00125	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—HDAC1—hypertension	4.39e-05	0.00121	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NEDD4L—hypertension	4.28e-05	0.00118	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—AR—hypertension	4.27e-05	0.00118	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hypertension	4.23e-05	0.00116	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hypertension	4.19e-05	0.00115	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—TGFB1—hypertension	4.17e-05	0.00115	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—EP300—hypertension	4.14e-05	0.00114	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—VEGFA—hypertension	3.92e-05	0.00108	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—TNF—hypertension	3.89e-05	0.00107	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—VDR—hypertension	3.84e-05	0.00106	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—GATA4—hypertension	3.72e-05	0.00103	CbGpPWpGaD
Loteprednol—Hydrocortisone—NR3C1—hypertension	3.55e-05	0.00617	CrCbGaD
Loteprednol—Dexamethasone—CYP3A5—hypertension	3.54e-05	0.00616	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—TNF—hypertension	3.36e-05	0.000926	CbGpPWpGaD
Loteprednol—Dexamethasone—CYP19A1—hypertension	3.26e-05	0.00567	CrCbGaD
Loteprednol—NR3C1—Gene Expression—NPPA—hypertension	3.24e-05	0.000893	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—PPARA—hypertension	3.24e-05	0.000891	CbGpPWpGaD
Loteprednol—Triamcinolone—PTGS2—hypertension	3.15e-05	0.00548	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—IL6—hypertension	3.14e-05	0.000865	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NOTCH1—hypertension	2.84e-05	0.000781	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL6—hypertension	2.71e-05	0.000747	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—PPARG—hypertension	2.68e-05	0.000737	CbGpPWpGaD
Loteprednol—Dexamethasone—NR3C1—hypertension	2.64e-05	0.0046	CrCbGaD
Loteprednol—Betamethasone—PTGS2—hypertension	2.58e-05	0.00449	CrCbGaD
Loteprednol—NR3C1—Gene Expression—CTGF—hypertension	2.55e-05	0.000701	CbGpPWpGaD
Loteprednol—Prednisone—ALB—hypertension	2.54e-05	0.00443	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—SERPINE1—hypertension	2.41e-05	0.000664	CbGpPWpGaD
Loteprednol—Dexamethasone—CYP1A1—hypertension	2.4e-05	0.00417	CrCbGaD
Loteprednol—Methyltestosterone—ALB—hypertension	2.38e-05	0.00414	CrCbGaD
Loteprednol—NR3C1—Gene Expression—ESR2—hypertension	2.33e-05	0.000641	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NOTCH2—hypertension	2.21e-05	0.000607	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—HDAC1—hypertension	2.11e-05	0.000582	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—AR—hypertension	2.06e-05	0.000566	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—VDR—hypertension	1.85e-05	0.000509	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—H2AFX—hypertension	1.75e-05	0.000482	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PRKCA—hypertension	1.7e-05	0.000469	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—YWHAZ—hypertension	1.69e-05	0.000465	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PRKCD—hypertension	1.63e-05	0.000448	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PPARA—hypertension	1.56e-05	0.000429	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—MYC—hypertension	1.53e-05	0.00042	CbGpPWpGaD
Loteprednol—Dexamethasone—PTGS2—hypertension	1.5e-05	0.00261	CrCbGaD
Loteprednol—NR3C1—Gene Expression—NOTCH1—hypertension	1.36e-05	0.000376	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PPARG—hypertension	1.29e-05	0.000355	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—SERPINE1—hypertension	1.16e-05	0.00032	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—MYC—hypertension	7.34e-06	0.000202	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—AKT1—hypertension	5.09e-06	0.00014	CbGpPWpGaD
